Based on the interest of the European PID research groups applying to participate, the ERMC organising committee will make the final decision about the topics of the day including the abstracts selected for oral presentation. All research groups will be directly informed about the selected topics, abstracts and groups before February 28, 2018.
ERMC 2018 Programme Celebrating its 10th anniversary:
9.00-9.20 Welcome and introduction
9.20-9.40 The role of the ERMC in our research group.
Cristiana Nascimento-Carvalho (Brazil-Finland PID Research Group) Dominique Kelly (Oxford Vaccine Group)
Session I: Vaccines and Vaccination Responses
9.40-10.05 The immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against group B and non-B meningococcal strains.
Kimberly Davis (Oxford)
10.05-10.30 BCG policy change and childhood tuberculosis in Finland – a retrospective population-based study from 1995 to 2015.
A. Kontturi (Finland)
10.30-10.55 The effect of S. typhi on the small-RNA transcriptome of peripheral blood mononucleocytes in Man.
Ruth Drury (Oxford)
10.55-11.25 Coffee Break
Workshop: The importance of study design 11.25-12.00
Study Design; the basics
12.00-12.20 Vaccination status and attitudes among parents of children with autism spectrum disorders in Poland.
Anna Piwowarczyk (Poland)
12.20-12.40 7-day compared with 10-day antibiotic treatment for febrile urinary tract infections in children, a randomised controlled trial.
Maria Daniel (Poland)
12.40-13.00 Vitamine D and susceptibility to infections during infancy.
Maria Zacharioudaki (Crete)
13.45-14.45 Keynote lecture
"Grant writing; top 10 tips."
Session III: Microbiome
14.45-15.10 Microbiome in neonates after delayed or immediate umbilical cord clamping during birth.
Eftychia Drogouti (Greece)
15.10-15.35 Gut microbiota is associated with markers of vascular endothelium activation in HIV+ children on ART.
Libera Sessa (Italy)
15.35-16.00 Coffee Break
Session IV: Viral and bacterial infections
16.00-16.25 Cerebrospinal fluid aspects of neonates born to mothers with gestational ZIKA virus clinical symptoms.
Clara Ramos (Brazil)
16.25-16.50 Is Hospital Onset Bacteremia a more accurate measure for surveillance of hospital acquired bacteremia?
Eleni Kourkouni (Greece)
16.50-17.15 Immunological markers of protection in infants with RSV bronchiolitis: is there role for peripheral T follicular cells (pTFH)?
Paola Zangari (Italy)
17.15-18.05 Enhancement of neonatal phagocyte responses facilitates group B streptococcal clearance and protects from neonatal sepsis.
Eleni Vergadi (Crete)
18.05-18.30 Closing remarks and Awards
Jussi Mertsola Ronald de Groot Nicole Ritz
|If you have submitted an application to participate in the Masterclass, please do not register to the Meeting until notification of acceptance to the Masterclass has been sent to you. |